文献速递腹部泌尿生殖MR

使用T1 mapping与IVIM-DWI评估COVID-19幸存者肝脏和肾脏动态影像变化

Assessment of dynamic hepatic and renal imaging changes in COVID-19 survivors using T1 mapping and IVIM-DWI.
PubMed 文献 · Abdom Radiol (NY) · 2022-03-13

前瞻性纳入37例出院COVID-19患者和24例年龄匹配的非COVID-19志愿者,行腹部VFA T1 mapping和IVIM-DWI,其中23例出院患者在3个月和1年随访时接受两次MRI。3个月随访组肝T1值最低、肝ADC及D值及肾皮质ADC和f值最高;1年随访组肝D值较3个月随访组显著降低;重症患者肝D*和f*D*值显著高于非重症患者。

要点

  • COVID-19幸存者3个月随访时肝T1值显著低于对照组,肝ADC和D值、肾皮质ADC和f值显著高于对照组。
  • 1年随访时肝D值较3个月随访显著降低,提示肝脏影像参数随时间变化。
  • 重症患者肝D*和f*D*值显著高于非重症患者;肾脏参数变化可能长期存在。

核心结论

  • T1 mapping和IVIM-DWI检测到的肝、肾影像参数动态变化提示COVID-19幸存者可能出现轻度、无症状的肝、肾损伤,其中肝损伤可能随时间缓解,而肾损伤可能长期存在。

研究设计与样本

  • 前瞻性研究,纳入37例出院COVID-19患者(COVID-19组)和24例年龄匹配的非COVID-19志愿者(对照组),其中23例出院患者接受两次随访MRI分别作为3个月随访组和1年随访组;采用可变翻转角(VFA)T1 mapping和体素内不相干运动扩散加权成像(IVIM-DWI)行腹部MRI,收集人口学、临床特征和实验室检查,测量肝、肾影像参数并进行组间比较。

诊断标准与关键数值

  • 3个月随访组肝T1值最低,显著低于对照组(P < 0.001)。
  • 3个月随访组肝ADC和D值、肾皮质ADC和f值最高,均显著高于对照组(P < 0.05)。
  • 1年随访组肝D值较3个月随访组显著降低(P = 0.001)。
  • 重症患者肝D*和f*D*值显著高于非重症患者(P = 0.031,P = 0.015)。

临床应用与阅片要点

  • 对COVID-19幸存者行腹部MRI时,可关注肝T1值、肝ADC和D值及肾皮质ADC和f值的动态变化,3个月随访时这些参数与对照组差异显著。
  • 随访中肝D值从3个月到1年显著降低,提示肝脏影像参数随时间演变;重症患者肝D*和f*D*值显著高于非重症患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the imaging changes of the liver and kidneys in COVID-19 survivors using variable flip angle (VFA) T1 mapping and intravoxel incoherent motion-diffusion weighted imaging (IVIM-DWI).

METHODS: This prospective study included 37 discharged COVID-19 participants and 24 age-matched non-COVID-19 volunteers who underwent abdominal MRI with VFA T1 mapping and IVIM-DWI sequencing as a COVID-19 group and control group, respectively. Among those discharged COVID-19 participants, 23 patients underwent two follow-up MRI scans, and were enrolled as the 3-month follow-up group and 1-year follow-up group, respectively. The demographics, clinical characteristics, and laboratory tests were collected. Imaging parameters of the liver and kidneys were measured. All collected values were compared among different groups.

RESULTS: The 3-month follow-up group had the lowest hepatic T1 value, which was significantly lower than the value in the control group (P < 0.001). Additionally, the 3-month follow-up group had the highest hepatic ADC and D values, cortical ADC and f values, which were significantly higher than those in the control group (for all, P < 0.05). The hepatic D value in the 1-year follow-up group decreased significantly in comparison with that in the 3-month follow-up group (P = 0.001). Compared to non-severe patients, severe cases had significantly higher hepatic D* and f*D* values (P = 0.031, P = 0.015, respectively).

CONCLUSION: The dynamic alterations of hepatic and renal imaging parameters detected with T1 mapping and IVIM-DWI suggested that COVID-19 survivors might develop mild, non-symptomatic liver and kidney impairments, of which liver impairment could probably relieve over time and kidney impairment might be long-existing.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Han, Lu, Wang, et al. Assessment of dynamic hepatic and renal imaging changes in COVID-19 survivors using T1 mapping and IVIM-DWI. Abdom Radiol (NY). 2022. PMID: 35279759. doi:10.1007/s00261-022-03471-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。